| Dinaciclib studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · 18 trials list this drug (2 active) | — | — | Melanoma,Cutaneous Nodular Melanoma,Mucosal Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434316Phase 1 · active not recruiting Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors · 18 trials list this drug (2 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03484520Phase 1 · terminated A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 18 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01676753Phase 1 · completed Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer · 18 trials list this drug (2 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684617Phase 1 · terminated Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155) · 18 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711528Phase 1 · completed Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · 18 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01624441Phase 1 · completed Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer · 18 trials list this drug (2 active) | — | — | Breast Carcinoma,Male Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01515176Phase 1/Phase 2 · completed Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia · 18 trials list this drug (2 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871910Phase 1 · completed Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) · 18 trials list this drug (2 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783171Phase 1 · completed Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery · 18 trials list this drug (2 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026324Phase 1/Phase 2 · terminated Dinaciclib in Treating Patients With Stage III-IV Melanoma · 18 trials list this drug (2 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01580228Phase 3 · completed A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714) · 18 trials list this drug (2 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871546Phase 2 · terminated SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) · 18 trials list this drug (2 active) | — | — | Leukemia,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00732810Phase 2 · completed SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) · 18 trials list this drug (2 active) | — | — | Breast Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871663Phase 1 · completed Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) · 18 trials list this drug (2 active) | — | — | Solid Neoplasm,Leukemia,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01650727Phase 1 · completed A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974) · 18 trials list this drug (2 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00798213Phase 2 · terminated SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) · 18 trials list this drug (2 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01096342Phase 2 · completed Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma · 18 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |